JULIO BELARMINO
BOBES GARCIA
Investigador hasta 2022
![Foto de María Teresa](/img/nophoto.png)
María Teresa
Bascarán Fernández
Publicaciones en las que colabora con María Teresa Bascarán Fernández (51)
2016
-
A review of quality-of-life assessment measures in schizophrenia: Limitations and future developments
Beyond Assessment of Quality of Life in Schizophrenia (Springer International Publishing), pp. 65-77
-
Treatments for Opioid Dependence and Methadone: Neurological and Behavioral Aspects
Neuropathology of Drug Addictions and Substance Misuse (Elsevier Inc.), pp. 595-602
2015
-
Psychometric evaluation of the negative syndrome of schizophrenia
European Archives of Psychiatry and Clinical Neuroscience, Vol. 265, Núm. 7, pp. 559-566
2014
-
Long term outcomes of pharmacological treatments for opioid dependence: Does methadone still lead the pack?
British Journal of Clinical Pharmacology, Vol. 77, Núm. 2, pp. 272-284
2013
-
Evolución de la prevalencia administrativa de los trastornos mentales durante 13 años en Asturias (norte de España)
Revista de Psiquiatria y Salud Mental, Vol. 6, Núm. 2, pp. 60-66
2012
-
Functional impairment as a defining feature of: Amnestic MCI cognitive, emotional, and demographic correlates
International Psychogeriatrics, Vol. 24, Núm. 9, pp. 1494-1504
2011
-
A cross-cultural comparison between Spain and the USA: Temperament and character distribution by sex and age
Psychiatry Research, Vol. 186, Núm. 2-3, pp. 397-401
-
Disertaciones sobre psiquiatría
Fundación Española de Psiquiatría y Salud Mental
-
Role of serotonergic-related systems in suicidal behavior: Data from a case-control association study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Núm. 6, pp. 1518-1524
-
Self-perceived needs are related to violent behavior among schizophrenia outpatients
Journal of Nervous and Mental Disease, Vol. 199, Núm. 9, pp. 666-671
-
Sixth version of the Addiction Severity Index: Assessing sensitivity to therapeutic change and retention predictors
International journal of clinical and health psychology, Vol. 11, Núm. 3, pp. 495-508
-
Validación de la versión española de la escala de Funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable
Revista de Psiquiatria y Salud Mental, Vol. 4, Núm. 1, pp. 9-18
2010
-
Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 34, Núm. 1, pp. 26-31
-
Impact of substance use on the physical health of patients with bipolar disorder
Acta Psychiatrica Scandinavica, Vol. 121, Núm. 6, pp. 437-445
-
Interactions between functional serotonergic polymorphisms and demographic factors influence personality traits in healthy Spanish Caucasians
Psychiatric Genetics, Vol. 20, Núm. 4, pp. 171-178
2009
-
Cardiovascular risk in patients with bipolar disorder
Journal of Affective Disorders, Vol. 115, Núm. 3, pp. 302-308
-
Differential role of serotonergic polymorphisms in alcohol and heroin dependence
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 33, Núm. 4, pp. 695-700
-
Role of serotonergic polymorphisms in the clinical severity of the panic disorder
Revista de Psiquiatria y Salud Mental, Vol. 2, Núm. 1, pp. 35-41
2008
-
Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts
Psychiatric Genetics, Vol. 18, Núm. 5, pp. 213-218
-
Association study between obsessive-compulsive disorder and serotonergic candidate genes
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, Núm. 3, pp. 765-770